Los puntos clave no están disponibles para este artículo en este momento.
The existence of circulating microRNAs (miRNAs) in the blood of cancer patients has raised the possibility that miRNAs may serve as a novel diagnostic marker. However, the secretory mechanism and biological function of extracellular miRNAs remain unclear. Here, we show that miRNAs are released through a ceramide-dependent secretory machinery and that the secretory miRNAs are transferable and functional in the recipient cells. Ceramide, whose biosynthesis is regulated by neutral sphingomyelinase 2 (nSMase2), triggers secretion of small membrane vesicles called exosomes. The decreased activity of nSMase2 with a chemical inhibitor, GW4869, and a specific small interfering RNA resulted in the reduced secretion of miRNAs. Complementarily, overexpression of nSMase2 increased extracellular amounts of miRNAs. We also revealed that the endosomal sorting complex required for transport system is unnecessary for the release of miRNAs. Furthermore, a tumor-suppressive miRNA secreted via this pathway was transported between cells and exerted gene silencing in the recipient cells, thereby leading to cell growth inhibition. Our findings shed a ray of light on the physiological relevance of secretory miRNAs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Nobuyoshi Kosaka
Tokyo Medical University
Haruhisa Iguchi
Hyogo Medical University
Yusuke Yoshioka
Tokyo Medical University
Journal of Biological Chemistry
National Cancer Research Institute
National Cancer Centre Japan
Sumitomo Dainippon Pharma (Japan)
Building similarity graph...
Analyzing shared references across papers
Loading...
Kosaka et al. (Tue,) studied this question.
synapsesocial.com/papers/69d7673cb1cb92dd1bb8aebe — DOI: https://doi.org/10.1074/jbc.m110.107821
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: